When a Prescription Change Is a Warning Sign
Every myopic child’s prescription changes. What matters is how fast, at what age, and which way the trend points, because those three together decide whether you are watching normal development or a problem accumulating. This page gives you the numbers to read your own child’s history, and an account of what another year of waiting costs.
On this page
What Progressive Myopia Is
What is progressive myopia?
Progressive myopia is nearsightedness that keeps increasing, usually year on year through childhood, because the eyeball is continuing to elongate. The term describes a trajectory rather than a severity. A child at minus one who gains three quarters of a diopter a year is progressive. A child at minus five who has not changed in three years is not.
The distinction matters because treatment decisions follow the trajectory, not the current number. Myopia control acts on future growth and cannot recover what is already accumulated, so the question is how much more is coming.
Progression is not steady either. Children go through faster and slower stretches, often accelerating in the year or two after onset. That is why one interval between two exams is a weak basis for a decision and a multi-year history is a strong one.
How Fast Is Too Fast
There is no single threshold, and anyone offering one is simplifying. Clinicians interpret rate against age. These are the reference points we use.
| Annual change | At age 7 to 9 | At age 10 to 12 | At age 13 to 16 |
|---|---|---|---|
| Under 0.25 D | Reassuring, keep monitoring | Reassuring | Likely stabilising |
| 0.25 to 0.50 D | Act, this compounds | Worth treating | Worth discussing |
| 0.50 to 1.00 D | Treat, high priority | Treat | Treat |
| Over 1.00 D | Urgent, review promptly | Urgent | Unusual, investigate |
In axial length terms, the better measure, sustained growth beyond roughly 0.2 millimetres per year in a school-age myopic child is where we want an active plan rather than observation. Around or below 0.1 millimetres per year is what a control program aims for. See Axial Length Monitoring.
When to Intervene
As soon as progression is documented. The specific triggers we act on are these.
- Any documented increase under age ten. Young onset is the strongest predictor of a high adult prescription, and the years just after onset are the fastest.
- Half a diopter or more in a year at any school age. Sustained across the remaining growth years, that means a much higher endpoint.
- Axial growth beyond about 0.2 millimetres a year. The more reliable version of the same trigger.
- Two myopic parents plus any progression. Genetic loading raises the expected endpoint independently of the current rate.
- Two consecutive annual exams that stepped up. Two points make a line, and that is enough.
There are situations where we advise against treating. A teenager stable for two years with flat biometry does not need a control program, though they may still want Ortho-K for daytime freedom. A household that cannot commit to nightly hygiene should choose something else.
What Another Year of Waiting Costs
"Let us see where we are next year" is the most common recommendation parents receive, and it is fair when the rate is genuinely slow. When it is not slow, be explicit about what the year buys and what it spends.
What waiting a year gives you
- One more data point on the progression trend
- A child who may be more ready to handle lenses
- No program cost incurred this year
- Time to research and think it through properly
What waiting a year spends
- A year of progression at the current rate, permanently
- A year taken from the fastest part of the growth window
- A higher starting point for whatever you do next
- No baseline axial length, so next year has nothing to compare against
There is a middle path we often recommend: get a baseline axial length measurement now, even if you are not ready to treat. It takes seconds, needs no drops, and means that in twelve months you have real data rather than another quarter-diopter step. A consultation and candidacy evaluation starts at $250 and is credited toward a program, and you receive your exact figure in writing before you commit.
Childhood Myopia Management covers the options, and Long-Term Eye Health covers what the endpoint means.
Frequently Asked Questions
The prescription went up by 0.25. Is that progression?
It may be, and one step is weak evidence either way. Prescriptions come in quarter-diopter increments, so a single step can be rounding or a real change already underway at the last exam.
Two consecutive steps in the same direction is meaningful. A single step in a young child is worth a baseline axial length measurement.
When does myopia stop progressing?
Most people stabilise in their late teens to early twenties, slowing steadily rather than stopping abruptly. A minority continue into their twenties, particularly with heavy near work. Confirm stability by measurement over two years rather than assuming it from age.
My child jumped a full diopter in one year. What happened?
Usually a fast-progressing period, which is not unusual in the couple of years after onset. It is a strong signal to act, not a sign that something went wrong.
Occasionally a large jump reflects a measurement issue or an accommodative problem rather than true axial change. A cycloplegic refraction plus biometry distinguishes them.
Can progression be stopped completely?
Rarely, and it is not what treatment promises. Some children show near-flat axial length for a period, but the realistic goal is a slower rate, because eyes grow during childhood.
A child growing 0.1 millimetres a year having previously grown 0.35 is a good result even though the number rose.
Would under-correcting the glasses slow it down?
No. This has been studied specifically. Deliberate under-correction does not slow progression, some studies found it slightly accelerated progression, and it leaves the child seeing worse meanwhile. It is a persistent idea because it feels intuitive, and the evidence does not support it.
What should I bring to a consultation about progression?
Every past prescription you can find, with dates, including school screenings and pediatrician records. Current glasses or contacts. A rough account of onset, when you first noticed squinting or complaints about the board.
Also useful: whether either parent is myopic and at what age it started.
Keep reading
Last updated . Clinically reviewed by Dr. Mark Page.